跳至主要内容
临床试验/NCT05230238
NCT05230238招募中不适用

Pituitary Gland Stimulation for Cancer Pain Relief

Leiden University Medical Center1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2021年10月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10
试验地点
1
主要终点
Pain Medication

研究概览

简要总结

Patients will undergo an implantation of an extradural pituitary surface electrode in the pituitary fossa. The electrode will be attached to a neurostimulator via which the patient will receive up to 8 (patient requested) stimulations per day.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patient
  • In palliative phase of metastatic disease, without options for further systemic treatment or radiotherapy
  • Inadequately controlled pain with standard care
  • Most prominent part of experienced pain is nociceptive
  • Karnofsky Performance Score ≥30

排除标准

  • Not fit for general anesthesia
  • Pregnancy
  • Unfavorable local anatomy for PGS, due to a disease process, or anatomical configuration
  • Clinical signs of posterior pituitary gland disfunction
  • Recent history of alcohol or drug abuse
  • Severe immunodeficiency
  • Need for anticoagulation therapy that cannot be abrogated for surgery
  • Need for subsequent MRI-imaging
  • Cognitive impairments prohibiting full understanding of study and ability to provide informed consent
  • Not able to adequately communicate in Dutch or English

结局指标

主要结局

Pain Medication

时间窗: 4 months

Morphine Equivalent Doses for background and escape medication

Perceived pain

时间窗: 4 months

Numeric Rating Scale (0= no pain, 10=most severe pain)

次要结局

未报告次要终点

研究者

发起方
Leiden University Medical Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

wrvanfurth

neurosurgeon

Leiden University Medical Center

研究点 (1)

Loading locations...

相似试验